Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial

Open access
Mattle, Heinrich P., Evers, Stefan, Hildick-Smith, David, Becker, Werner J., Baumgartner, Helmut, Chataway, Jeremy, Gawel, Marek, Göbel, Hartmut, Heinze, Axel, Horlick, Eric, Malik, Iqbal, Ray, Simon, Zermansky, Adam, Findling, Oliver, Windecker, Stephan, Meier, Bernhard · 2016 · European Heart Journal

Abstract

AIMS: Migraine with aura and patent foramen ovale (PFO) are associated. The Percutaneous Closure of PFO in Migraine with Aura (PRIMA) trial is a multicentre, randomized trial to investigate the effect of percutaneous PFO closure in patients refractory to medical treatment. METHODS: Migraine with aura patients and PFO who were unresponsive to preventive medications were randomized to PFO closure or medical treatment. Both groups were given acetylsalicylic acid 75-100 mg/day for 6 months and clopidogrel 75 mg/day for 3 months. The primary endpoint was reduction in monthly migraine days during months 9-12 after randomization compared with a 3-month baseline phase before randomization. The committee reviewing the headache diaries were blinded to treatment assignment. RESULTS: One hundred and seven patients were randomly allocated to treatment with an Amplatzer PFO Occluder (N = 53) or control with medical management (N = 54). The trial was terminated prematurely because of slow enrolment. Eighty-three patients (40 occluder, 43 control) completed 12-month follow-up. Mean migraine days at baseline were 8 (±4.7 SD) in the closure group and 8.3 (±2.4) in controls. The primary endpoint was negative with -2.9 days after PFO closure vs. -1.7 days in control group (P = 0.17). Patent foramen ovale closure caused five adverse events without permanent sequelae. CONCLUSION: In patients with refractory migraine with aura and PFO, PFO closure did not reduce overall monthly migraine days.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw027

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 223

Metadata

Authors
Mattle, H. P., Evers, S., Hildick-Smith, D., Becker, W. J., Baumgartner, H., Chataway, J., Gawel, M., Göbel, H., Heinze, A., Horlick, E., Malik, I., Ray, S., Zermansky, A., Findling, O., Windecker, S., & Meier, B.
Venue
European Heart Journal
Published
2016-02-22
Volume
37
Issue
26
Pages
2029-2036
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2302536755
Cited by
223
References
5
FWCI
18.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehw027
The paper
Mattle, H. P., Evers, S., Hildick-Smith, D., Becker, W. J., Baumgartner, H., Chataway, J., Gawel, M., Göbel, H., Heinze, A., Horlick, E., Malik, I., Ray, S., Zermansky, A., Findling, O., Windecker, S., & Meier, B. (2016). Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.